New heads of neuro, immunology at Lilly, and more biopharma moves

Eli Lilly and Co. (NYSE:LLY) unveiled changes to its senior leadership in preparation for what it characterized as its next wave of growth, including naming Carole Ho EVP and president of Lilly Neuroscience. Ho was most recently CMO of neurology play Denali Therapeutics Inc. (NASDAQ:DNLI).

The pharma promoted Adrienne Brown to EVP and president of Lilly Immunology. She was previously group VP of corporate business development, which will now be moved under the leadership of Jacob Van Naarden, who remains EVP and president of Lilly Oncology. ...